DiaMedica Therapeutics is a clinical-stage biopharmaceutical company committed to changing the treatment paradigm for acute ischemic stroke (AIS) and cardio-renal disease. Our initial product candidate, DM199, mimics the behavior of naturally..
Relevance: 11.063411